| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
![]() | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
![]() | 8 | 9 | 10 | 11 | 12 | 13 | 14 |
![]() | 15 | 16 | 17 | 18 | 19 | 20 | 21 |
![]() | 22 | 23 | 24 | 25 | 26 | 27 | 28 |
![]() | 29 | 30 | 31 |
BIOSIGNAL LIMITED (BOS)
Stock Code: BOS
Listing Date: 2000-06-28 00:00:00
Website: http://www.biosignal.com.au
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Development of novel anti-bacterials
Address:
Australian Technology Park, National Innovation Centre, Level 1, Suite 145
EVELEIGH
NSW 1430
Phone: (02) 9209 4126
Fax: (02) 9209 4306
Executives & Directors
Dr John S Keniry, Chairman
Prof. Peter D Steinberg, Director, CEO
Mr Bruce E Foy, Non Exec. Director
Mr Robert C Vickery, CFO
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
|
Excellence in Biotechnology Investment - Professor Peter Steinberg, CEO, BioSignal Ltd
|
|
Wed, 23 Apr 2008 03:30PM |
|
BOS - Collaboration to Develop Dental Devices - Mr Michael Oredsson, MD and CEO
|
|
Tue, 9 Jan 2007 02:00PM |
| Annual General Meeting | Tue, 25 Nov 2008 10:00AM |
|
| Full Year Results | Fri, 29 Aug 2008 | |
| EGM | Thu, 29 May 2008 12:30PM |
|
| Interim Results | Thu, 28 Feb 2008 | |
| Annual General Meeting | Fri, 23 Nov 2007 10:00AM |
|
| Full Year Results | Mon, 27 Aug 2007 | |
| Interim Results | Wed, 28 Feb 2007 | |
| Annual General Meeting | Fri, 24 Nov 2006 10:00AM |
|
| Full Year Results | Wed, 30 Aug 2006 | |
| Interim Results | Mon, 13 Mar 2006 | |
| Annual General Meeting | Fri, 25 Nov 2005 10:00AM |
BIOSIGNAL LIMITED (BOS)
| Appendix 4C - quarterly | Fri, 26 Oct 2007 |
| Initiates Oil and Gas Field Trial on positive UK results | Thu, 25 Oct 2007 |
| Notice of Annual General Meeting | Fri, 19 Oct 2007 |
| Annual Report to shareholders | Fri, 28 Sep 2007 |
| Vesting of Options | Fri, 28 Sep 2007 |
| Shareholder Newsletter | Wed, 29 Aug 2007 |
| Preliminary Final Report | Mon, 27 Aug 2007 |
| Appendix 3B | Fri, 24 Aug 2007 |
| Final Director`s Interest Notice-Michael Oredsson | Mon, 13 Aug 2007 |
| Presentation by CEO Peter Steinberg | Mon, 6 Aug 2007 |
| Presentation by Director Gunter Pauli | Mon, 6 Aug 2007 |
| Biosignal partners to penetrate Japanese market | Thu, 26 Jul 2007 |
| Oil and Gas Antibacterial to be tested in Oilfield Condition | Tue, 24 Jul 2007 |
| Appendix 4C - quarterly | Thu, 19 Jul 2007 |
| Biosignal Initiates Product Registration | Tue, 10 Jul 2007 |
| Biosignal appoints interim CEO | Mon, 2 Jul 2007 |
| Lapse of unlisted Options | Mon, 2 Jul 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.
